Mirum Pharmaceuticals, Inc. (MIRM) Operating cash flow 2019–2025
Mirum Pharmaceuticals, Inc. (MIRM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$55.8MFY2025 · since FY2019: -$39.4M → $55.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $55.8M | +440.7% |
| FY2024 | $10.3M | +114.6% |
| FY2023 | -$70.9M | +40.9% |
| FY2022 | -$120.1M | +9.5% |
| FY2021 | -$132.8M | -49.0% |
| FY2020 | -$89.1M | -126.3% |
| FY2019 | -$39.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MIRM financial trends
MIRM RevenueMIRM Net incomeMIRM Net marginMIRM Gross profitMIRM Gross marginMIRM Operating incomeMIRM Operating marginMIRM Free cash flowMIRM Capital expendituresMIRM Return on equityMIRM Stock buybacksMIRM Dividends paidMIRM Total assetsMIRM Total liabilitiesMIRM Shareholders’ equityMIRM overview →